Physiopathology of rosacea. Redness, telangiectasia, and rosacea

被引:0
|
作者
Cribier, B. [1 ,2 ]
机构
[1] Univ Strasbourg, Dermatol Clin, Fac Med, F-67091 Strasbourg, France
[2] Hop Univ Strasbourg, F-67091 Strasbourg, France
来源
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE | 2011年 / 138卷
关键词
Rosacea; Facial telangiectasia; Demodex folliculorum; Innate immunity; Telangiectasias; GROWTH-FACTOR; ANGIOGENESIS; PATHOGENESIS; RHINOPHYMA; CELLS;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
The physiopathology of rosacea involves a large number of factors that are at times difficult to correlate. There is not a single physiopathological model. Nevertheless, today it seems to have been established that two essential factors are involved: vascular and inflammatory. The disease occurs in individuals with a predisposition, mainly a light phototype subjected to substantial variations in climate. On a background of primary vascular anomaly, external factors (climate, exposure to ultraviolet rays, cutaneous flora, etc.) contribute to the development of abnormal superficial blood vessels, with a low permeability. The edema that results undoubtedly favors the colonization and multiplication of Demodex folliculorum. This parasite creates inflammation, directly and indirectly, which is seen in the papules and pustules as well as granulomas. Inflammation from rosacea is also characterized by innate immune system anomalies, with an increase in the expression of epidermal proteases and production of pro-inflammatory cathelicidin peptides. In addition, facial hypersensitivity exists, even though the cutaneous barrier is not altered. Finally, rhinophyma remains poorly explained; the vascular abnormalities induce local production of transforming growth factor B 1 (TGF-B1) capable of creating fibrosis and therefore cutaneous thickening. (C) 2011 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:S129 / S137
页数:9
相关论文
共 50 条
  • [31] The molecular pathology of rosacea
    Yamasaki, Kenshi
    Gallo, Richard L.
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2009, 55 (02) : 77 - 81
  • [32] Rosacea: A clinicopathological approach
    Aroni, K
    Tsagroni, E
    Lazaris, AC
    Patsouris, E
    Agapitos, E
    DERMATOLOGY, 2004, 209 (03) : 177 - 182
  • [33] Signs and symptoms of rosacea
    Schmutz, J. -L.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2014, 141 : S151 - S157
  • [34] Blushing in rosacea sufferers
    Drummond, Peter D.
    Su, Daphne
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2012, 72 (02) : 153 - 158
  • [35] Update on the management of rosacea
    Weinkle, Allison P.
    Doktor, Vladyslava
    Emer, Jason
    CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2015, 8 : 159 - 176
  • [36] Rosacea Granulomatosis in a Neutropenic Leukemic Patient
    Lee, Woo Joo
    Kraitman, Natan
    Sarriera-Lazaro, Carlos J.
    Greene, John
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [37] Research advance in rosacea
    Qiuyu Wang
    Mahdi KFattah
    Xiaoge Li
    Rui Guo
    Chuan Cao
    重庆医学, 2017, 46 (07) : 974 - 982
  • [38] Immune signaling in rosacea
    Wladis, Edward J.
    Adam, Alejandro P.
    OCULAR SURFACE, 2021, 22 : 224 - 229
  • [39] Rosacea: Pathogenesis and Therapy
    Tan, Jerry K. L.
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2015, 34 : S75 - S77
  • [40] Rosacea: pathogenesis and therapy
    Webster, G. F.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2011, 146 (03): : 235 - 241